Loperamide Hydrochloride
- Product NDC
- 0378-2100
- 11-digit product format
- 003782100
- Labeler code
- 0378
- Product ID
- 0378-2100_84c39323-d4c3-452c-b89d-d104dcac4346
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- loperamide hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Mylan Pharmaceuticals Inc.
- Application
- ANDA072741
- Marketing category
- ANDA
- Marketing start
- 1991-09-18
- Substance
- LOPERAMIDE HYDROCHLORIDE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Opioid Agonist [EPC], Opioid Agonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Loperamide Hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LOPERAMIDE HYDROCHLORIDE | 2 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 77TI35393C |
| Rxcui | 978006 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0378-2100-01 | Loperamide Hydrochloride | 100 in 1 BOTTLE, PLASTIC | CAPSULE | 100 | | 14 |
| 0378-2100-05 | Loperamide Hydrochloride | 500 in 1 BOTTLE, PLASTIC | CAPSULE | 500 | | 14 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| LOPERAMIDE HYDROCHLORIDE | ACTIVE INGREDIENT | 77TI35393C | LOPERAMIDE HYDROCHLORIDE CAPSULE [MYLAN PHARMACEUTICALS INC.] | 5 | |
| LOPERAMIDE | ACTIVE MOIETY | 6X9OC3H4II | LOPERAMIDE HYDROCHLORIDE CAPSULE [MYLAN PHARMACEUTICALS INC.] | 5 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | LOPERAMIDE HYDROCHLORIDE CAPSULE [MYLAN PHARMACEUTICALS INC.] | 5 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | LOPERAMIDE HYDROCHLORIDE CAPSULE [MYLAN PHARMACEUTICALS INC.] | 5 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | LOPERAMIDE HYDROCHLORIDE CAPSULE [MYLAN PHARMACEUTICALS INC.] | 5 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | LOPERAMIDE HYDROCHLORIDE CAPSULE [MYLAN PHARMACEUTICALS INC.] | 5 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | LOPERAMIDE HYDROCHLORIDE CAPSULE [MYLAN PHARMACEUTICALS INC.] | 5 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | LOPERAMIDE HYDROCHLORIDE CAPSULE [MYLAN PHARMACEUTICALS INC.] | 5 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | LOPERAMIDE HYDROCHLORIDE CAPSULE [MYLAN PHARMACEUTICALS INC.] | 5 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | LOPERAMIDE HYDROCHLORIDE CAPSULE [MYLAN PHARMACEUTICALS INC.] | 5 | |
| LOPERAMIDE HYDROCHLORIDE | ACTIVE INGREDIENT | 77TI35393C | LOPERAMIDE HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.] | 4 | |
| LOPERAMIDE | ACTIVE MOIETY | 6X9OC3H4II | LOPERAMIDE HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.] | 4 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | LOPERAMIDE HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.] | 4 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | LOPERAMIDE HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.] | 4 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | LOPERAMIDE HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.] | 4 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | LOPERAMIDE HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.] | 4 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | LOPERAMIDE HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.] | 4 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | LOPERAMIDE HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.] | 4 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | LOPERAMIDE HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.] | 4 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | LOPERAMIDE HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.] | 4 | |
| LOPERAMIDE HYDROCHLORIDE | ACTIVE INGREDIENT | 77TI35393C | LOPERAMIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] | 2 | |
| LOPERAMIDE | ACTIVE MOIETY | 6X9OC3H4II | LOPERAMIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | LOPERAMIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] | 2 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | LOPERAMIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] | 2 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | LOPERAMIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] | 2 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | LOPERAMIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | LOPERAMIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] | 2 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | LOPERAMIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] | 2 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | LOPERAMIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] | 2 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | LOPERAMIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] | 2 | |
| LOPERAMIDE HYDROCHLORIDE | ACTIVE INGREDIENT | 77TI35393C | LOPERAMIDE HYDROCHLORIDE CAPSULE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | |
| LOPERAMIDE | ACTIVE MOIETY | 6X9OC3H4II | LOPERAMIDE HYDROCHLORIDE CAPSULE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | LOPERAMIDE HYDROCHLORIDE CAPSULE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | LOPERAMIDE HYDROCHLORIDE CAPSULE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | LOPERAMIDE HYDROCHLORIDE CAPSULE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | LOPERAMIDE HYDROCHLORIDE CAPSULE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | LOPERAMIDE HYDROCHLORIDE CAPSULE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | LOPERAMIDE HYDROCHLORIDE CAPSULE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | LOPERAMIDE HYDROCHLORIDE CAPSULE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | LOPERAMIDE HYDROCHLORIDE CAPSULE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0378-2100 | LOPERAMIDE HYDROCHLORIDE CAPSULE [MYLAN PHARMACEUTICALS INC.] | 14 | Current NDC, Legacy NDC, 2 package rows | 20240111_72a7ae47-cdf3-4949-b9f8-f29b153f787f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0378-2100-01 | 00378210001 | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-2100-01) | 100 capsule | 1991-09-18 | 0000-00-00 | No | No | Current |
| 0378-2100-05 | 00378210005 | 500 CAPSULE in 1 BOTTLE, PLASTIC (0378-2100-05) | 500 capsule | 1991-09-18 | 0000-00-00 | No | No | Current |